Ongoing Developments in Stem Cell Therapy are Driving the Global Stem Cell Therapy Market

Published: Jul 2022

The global stem cell therapy market is anticipated to grow at a CAGR of 15.8% during the forecast period. The ongoing developments in stem cell therapy are key factors driving the growth of the global stem cell therapy market. For instance, in July 2022, the Louisville-based National Stem Cell Foundation (NSCF) funded the first-in-kind study of neurodegeneration on the International Space Station (ISS) with a bi-coastal team of leading experts in the fields of Parkinson’s disease (PD) and multiple sclerosis (MS). The study uses organoids, 3-D aggregates of cells from PD and primary progressive MS (PPMS) patients that mimic the central nervous system, and microglia, the immune cells that have been recognized as playing a role in neurodegeneration. The project launched from Cape Canaveral on July 14 and travelled to the International Space Station for a fourth time aboard the SpaceX 25 Commercial Resupply Mission for NASA.

Browse the full report description of “Stem Cell Therapy Market Size, Share & Trends Analysis Report, By Type (Allogeneic and Autologous), By Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, and Autoimmune & Inflammatory), By Cell Source (Adipose Tissues, Bone Marrow, and Placenta/Umbilical Cord), Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/stem-cell-therapy-market

In June 2022, Lifespan Cancer Institute received approval to operate an autologous stem-cell therapy program at the Lifespan Cancer Institute at Rhode Island Hospital. The approval, which was granted by the State Health Services Council in a unanimous vote on June 16, will allow patients from the institute who need cancer treatments, such as stem-cell therapy which provides bone marrow transplants for patients undergoing chemotherapy, to receive care with their regular medical team. 

Market Coverage

The market number available for – 2021-2028

Base year- 2021

Forecast period- 2022-2028

Segment Covered- 

o By Type

o By Therapeutic Application

o By Cell Source

Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape- Smith & Nephew plc, MEDIPOST Co., Ltd., and Anterogen Co., Ltd., among others.

Key questions addressed by the report

What is the market growth rate?

Which segment and region dominate the market in the base year?

Which segment and region will project the fastest growth in the market?

How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

Who is the leader in the market?

How are players addressing challenges to sustain growth?

Where is the investment opportunity?

Global Stem Cell Therapy Market Report by Segment

By Type

  • Allogeneic
  • Autologous

By Therapeutic Application

  • Musculoskeletal
  • Wound & Injury
  • CVD
  • Autoimmune & Inflammatory

By Cell Source

  • Tissues
  • Bone Marrow
  • Placenta/Umbilical Cord

Global Stem Cell Therapy Market Report by Region

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe 

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific 

Rest of the World

Latin America 

Middle East & Africa


To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/stem-cell-therapy-market